ResearcherUniversity of AntwerpActive in the last 2 years
Delphine Quatannens
Matched on ORCID iD 0000-0001-5493-5539; OpenAlex author ID A5024413506. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 5
- Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns. Co-author DOI 10.1007/s00262-026-04343-w↗
- Capturing the Heterogeneity of the PDAC Tumor Microenvironment: Novel Triple Co-Culture Spheroids for Drug Screening and Angiogenic Evaluation. Co-author DOI 10.3390/cells14060450↗
- Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pharmthera.2022.108107↗
- Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. First author DOI 10.3390/cancers13050987↗
- Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment. Co-author DOI 10.1002/cti2.1165↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jonas R.M. Van Audenaerde · 5 shared papers, 2020–2026 · strength 0.83
- Paper Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns. DOI 10.1007/s00262-026-04343-w↗
- Paper Capturing the Heterogeneity of the PDAC Tumor Microenvironment: Novel Triple Co-Culture Spheroids for Drug Screening an… DOI 10.3390/cells14060450↗
- Paper Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pharmthera.2022.108107↗
- Geert Roeyen · 5 shared papers, 2020–2026 · strength 0.83
- Paper Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns. DOI 10.1007/s00262-026-04343-w↗
- Paper Capturing the Heterogeneity of the PDAC Tumor Microenvironment: Novel Triple Co-Culture Spheroids for Drug Screening an… DOI 10.3390/cells14060450↗
- Paper Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pharmthera.2022.108107↗
- Marc Peeters · 4 shared papers, 2020–2026 · strength 0.60
- Paper Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns. DOI 10.1007/s00262-026-04343-w↗
- Paper Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pharmthera.2022.108107↗
- Paper Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. DOI 10.3390/cancers13050987↗
- Evelien Smits · 4 shared papers, 2020–2025 · strength 0.59
- Paper Capturing the Heterogeneity of the PDAC Tumor Microenvironment: Novel Triple Co-Culture Spheroids for Drug Screening an… DOI 10.3390/cells14060450↗
- Paper Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pharmthera.2022.108107↗
- Paper Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. DOI 10.3390/cancers13050987↗
- Hans Prenen · 3 shared papers, 2021–2026 · strength 0.50
- Paper Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns. DOI 10.1007/s00262-026-04343-w↗
- Paper Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pharmthera.2022.108107↗
- Paper Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. DOI 10.3390/cancers13050987↗
- Christophe Deben · 2 shared papers, 2021–2025 · strength 0.34
- Ruben Verloy · 1 shared paper, 2025 · strength 0.23
- Angela Privat‐Maldonado · 1 shared paper, 2025 · strength 0.23
- Annemie Bogaerts · 1 shared paper, 2025 · strength 0.23
- Sara R. Zanivan · 1 shared paper, 2021 · strength 0.11
- Andreas Domen · 1 shared paper, 2021 · strength 0.11
- Timon Vandamme · 1 shared paper, 2021 · strength 0.11
- Jinthe Van Loenhout · 1 shared paper, 2020 · strength 0.09
- Clare Y. Slaney · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.